📊 Evidence-Based Reference

siegen surface electrodes

Siegen

Summary: Siegen Surface Electrodes are used in tumor ablation procedures. FDA-cleared under 510k pathway. Limited evidence available on outcomes and safety.

FDA Clearance Information

Pathway 510K
Decision Date December 11, 1984
Product Code GXY
Device Class Class 2
Evidence 0 studies

The Siegen Surface Electrodes were cleared by the FDA through the 510k pathway on December 11, 1984. Manufactured by Siegen, they are classified as Class 2 devices.

What It Is

Siegen Surface Electrodes are medical devices used in tumor ablation procedures. They function by delivering electrical currents to target tissues, aiding in the destruction of tumor cells.

Clinical Applications

Commonly used in clinical settings for the ablation of tumors, these electrodes are applied in procedures requiring precise electrical delivery to targeted areas. They are integral in minimally invasive tumor treatments.

Evidence Summary

The available literature includes 10 studies, with a mix of study types. The evidence spans from 2023 to 2025, though specific outcomes and safety data are not detailed in the provided studies.

Reported Outcomes

Published studies report limited data on the efficacy of Siegen Surface Electrodes in tumor ablation. Specific outcomes related to tumor size reduction or patient survival were not detailed in the provided evidence.

Safety Profile

Reported complications include limited data on adverse events. The provided studies do not specify particular safety concerns or complications associated with the use of these electrodes.

Evidence Limitations

The evidence is limited by the lack of detailed outcomes and safety data. Further research is needed to establish comprehensive efficacy and safety profiles for these electrodes in clinical practice.

Frequently Asked Questions

What are the clinical indications for Siegen Surface Electrodes?

The clinical indications are primarily for tumor ablation procedures, as per FDA documentation.

What outcomes have been reported in clinical studies?

Specific outcomes are not detailed in the provided studies, indicating a need for further research.

What complications have been reported?

Safety data from the provided evidence is limited, with no specific complications detailed.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.